These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28850676)

  • 1. Addressing Pharmaceutical Injuries: The US Landscape.
    Bakker C; Honig N
    Clin Pharmacol Ther; 2018 Mar; 103(3):384-385. PubMed ID: 28850676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product liability in respect of drugs.
    Diamond AL; Laurence DR
    Br Med J (Clin Res Ed); 1985 Feb; 290(6465):365-8. PubMed ID: 3917823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
    Smirniotopoulos A
    Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compensation for drug injury: two solutions to an insoluble problem.
    Smith R
    Br Med J (Clin Res Ed); 1981 May; 282(6276):1610-2. PubMed ID: 6786584
    [No Abstract]   [Full Text] [Related]  

  • 5. The HEALTH Act's FDA defense to punitive damages: a gift to drug makers or to the public?
    Levy E
    Fordham Law Rev; 2006 Mar; 74(4):2425-60. PubMed ID: 17115481
    [No Abstract]   [Full Text] [Related]  

  • 6. Compensation for drug injury. Problems both sides of the Atlantic.
    Smith R
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1443-5. PubMed ID: 6784859
    [No Abstract]   [Full Text] [Related]  

  • 7. Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels.
    Boumil MM; Curfman G
    JAMA; 2018 Aug; 320(6):547-548. PubMed ID: 30039167
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
    Gostin LO
    JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642
    [No Abstract]   [Full Text] [Related]  

  • 9. Compensating Pharmaceutical Injuries in the Absence of Fault.
    Rowin MA
    Food Drug Law J; 2014; 69(3):447-70, ii. PubMed ID: 27382858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
    Rostron A
    Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug product liability and health care delivery systems.
    Sage WM
    Stanford Law Rev; 1988 Apr; 40(4):989-1026. PubMed ID: 10318110
    [No Abstract]   [Full Text] [Related]  

  • 12. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 13. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal problems in psychiatric drug prescription.
    Appleton WS
    Am J Psychiatry; 1968 Jan; 124(7):877-82. PubMed ID: 5688683
    [No Abstract]   [Full Text] [Related]  

  • 15. The learned intermediary doctrine: past, present and future.
    Alsobrook HB
    Leg Med; 1994; ():269-80. PubMed ID: 7830482
    [No Abstract]   [Full Text] [Related]  

  • 16. Theories of recovery for DES damage. Is tort liability the answer?
    Downey AH; Gulley KG
    J Leg Med; 1983 Jun; 4(2):167-200. PubMed ID: 6604118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No-fault medical liability in Virginia and Florida. A preliminary evaluation.
    Patel K
    Eval Health Prof; 1995 Jun; 18(2):137-51. PubMed ID: 10143009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medicolegal aspects of adverse drug reactions.
    Bernstein HN; Levine AM
    Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801
    [No Abstract]   [Full Text] [Related]  

  • 19. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
    Joffe S; Lynch HF
    N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
    [No Abstract]   [Full Text] [Related]  

  • 20. Compensating the drug victim.
    Lancet; 1978 Jul; 2(8079):26. PubMed ID: 78220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.